Study Title: Phase I trial of Methotrexate, Rituximab, Lenalidomode, and Nivolumab (Nivo-MR2) Induction Followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Scott Lindhorst, at lindhors@musc.edu.Study Coordinator, Eva Newman, at newmanev@musc.edu.Trial opened at the following institutions: Medical University of South Carolina